Ovid Therapeutics, Inc. (OVID)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Ovid Therapeutics, Inc. (OVID)
Company Performance

Current Price

as of Oct 16, 2024

$1.18

P/E Ratio

N/A

Market Cap

$83.75M

Description

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Metrics

Overview

  • HQNew York, NY
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerOVID
  • Price$1.18+2.61%

Trading Information

  • Market Cap$83.75M
  • Float82.34%
  • Average Daily Volume (1m)113,865
  • Average Daily Volume (3m)183,289
  • EPS-$0.42

Company

  • Revenue$0.57M
  • Rev Growth (1yr)125.33%
  • Net Income$8.52M
  • Gross Margin12.43%
  • EBITDA Margin-12,052.66%
  • EBITDA-$20.37M
  • EV-$6.06M
  • EV/Revenue-10.68
  • P/EN/A
  • P/S147.45
  • P/B0.94
Documents